Clinical & Translational Immunology

Papers
(The TQCC of Clinical & Translational Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Intimal macrophages develop from circulating monocytes during vasculitis87
Early‐like differentiation status of systemic PD‐1+CD8+ T cells predicts PD‐1 blockade outcome in non‐small cell lung cancer59
Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates29
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis27
23
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis22
21
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis19
Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide19
Advances in bacteria‐based drug delivery systems for anti‐tumor therapy18
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival17
Siglec‐7 and Siglec‐9 expression in primary triple negative and oestrogen receptor positive breast cancer and in vitro signalling16
Cord blood granulocyte levels are associated with severe bronchiolitis in the first year of life16
Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint16
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant15
15
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation15
LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza14
13
13
Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients12
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection12
IL‐15‐induced CD38+HLA‐DR+CD8+ T cells correlate with liver injury via NKG2D in chronic hepatitis B cirrhosis12
Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma11
10
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease10
The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis10
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis10
Diversification and shared features of tumor‐binding antibody repertoires in tumor, sentinel lymph node and blood of three patients with breast cancer10
Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection10
Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials9
Autologous Epstein–Barr virus‐specific adoptive T‐cell therapy in a patient with lupus nephritis9
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?9
Dual CD47 and PD‐L1 blockade elicits anti‐tumor immunity by intratumoral CD8+ T cells9
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system8
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients8
Primary SARS‐CoV‐2 infection in children and adults results in similar Fc‐mediated antibody effector function patterns8
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease8
Anti‐signal recognition particle antibodies induce cardiac diastolic dysfunction via oxidative stress injury8
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients8
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models8
Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia7
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery7
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination7
The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities7
7
6
γδ T cells mediate robust anti‐HIV functions during antiretroviral therapy regardless of immune checkpoint expression6
Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma6
Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non‐criteria antibodies6
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC50 values predict SARS‐CoV‐2 neutralising antibody titres6
From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL‐336
6
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation6
5
5
Graft‐versus‐leukaemia immunity is retained following treatment with post‐transplant cyclophosphamide alone or combined with tocilizumab in humanised mice5
5
CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease5
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy5
From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 20195
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation5
5
Characterisation of novel influenza‐derived HLA‐B*18:01‐restricted epitopes5
0.066164016723633